RRAS2 and breast carcinoma: The 15 mouse tumor samples grouped closer to the Triple Negative breast cancers than to any of the others (Fig. 4c), thus confirming our immunohistochemical data (Fig. 1c, Fig. S1b), showing that the breast tumors emerging in mice overexpressing RRAS2 most closely resemble the TNBC subtype.